Bruce McGechan

I'm an M&A Advisor, Authorised Financial Adviser, an experienced company director, business consultant and marketing expert who has owned and worked with mid-market and corporate businesses over the last twenty odd years. I have a Masters of Entrepreneurship (Otago, with Distinction, 2010) with particular expertise in company valuation and fund raising. I also have a Bachelor of Commerce and Administration (Victoria, Accounting, 1991), and a Diploma in Japanese Studies (Keio, Japan, 1994).

I’ve worked in industries across manufacturing, tourism, beverages, hospitality, digital and creative industries. I started off in Fletcher Challenge New Ventures in 1994, before moving into sales and marketing in DB Breweries, Vodafone, Cardrona then owning my own business consulting firm from 2011 before joining Mandanex Capital in 2017.

I grew up in Wellington, and live here with my wife and two kids, and have also lived in Tokyo, Auckland and Central Otago for many years and spent many months in the US. I have an extensive Asian, American and Australian network.

Mandanex Capital

Mandanex Capital is a SME M&A Advisory firm (a specialist chartered accounting firm) with a head office in Sydney as well as offices in Singapore, Indonesia, and Germany. It is part of the Nexus International Group that includes Nexus Business Sales, a licensed REAA agent and has offices throughout New Zealand. The firms have superb buyer networks across New Zealand and Australia as well as Asia. As with all professional services firms, we pride ourselves on confidentiality.

Bruce McGechan and M&P Consulting

I act as a sole trader for the purposes of my AFA and the Financial Service Provider entity. This will change as the new legislation is bedded in and clarified, so I expect to create another entity in 2020 as part of complying with the Financial Services Legislation Amendment Act and the new association regulations.

M&P Consulting is my independent consulting business used where license requirements are not needed or inappropriate.